Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics, Inc. (Nasdaq: BNGO) offering CLIA-certified laboratory developed tests (LDTs) based on optical genome mapping (OGM), today announce ...

Bionano Laboratories, a wholly-owned subsidiary of Bionano Genomics (BNGO), announced that Centers for Medicare & Medicaid Services, CMS, posted ...

The company plans to raise money this fall to support the continued development of its head-and-neck cancer testing platform and oral squamous cell carcinoma test.

In the post-genomic era, long non-coding RNAs (lncRNAs) have emerged as critical regulators in various cancers and hold potential as minimally invasive diagnostic biomarkers. This study aimed to ...

The Business Research Company’s Somatic Genetic Testing Global Market Report 2025 – Market Size, Trends, And Forecast 2025-2034 ...